Hae Kyung Kwon

Title: Hae Kyung Kwon: Innovator in Anti-Cancer Compositions

Introduction

Hae Kyung Kwon is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of anti-cancer research through his innovative compositions. His work focuses on the combination of acridine derivatives and guanosine compounds to enhance anti-cancer effects.

Latest Patents

Hae Kyung Kwon holds a patent for an anti-cancer composition that includes acridine derivatives and guanosine compounds. The invention specifies a weight ratio of acridine derivative to guanosine compound ranging from 1:0.1 to 5.0, with preferred ratios being 1:0.3 to 3.0 and most preferably 1:0.5 to 1.5. The composition, particularly featuring acriflavine neutral and guanosine hydrate, demonstrates reduced toxicity and increased anti-cancer efficacy compared to the individual use of these compounds.

Career Highlights

Throughout his career, Hae Kyung Kwon has worked with various organizations, including Tae Rim Pharm. Co., Ltd. His research has focused on developing effective treatments for cancer, showcasing his commitment to improving patient outcomes.

Collaborations

Hae Kyung Kwon has collaborated with notable colleagues, including Yung Bok Han and Hong Ki Kyung. These partnerships have contributed to the advancement of his research and the development of innovative solutions in the field of oncology.

Conclusion

Hae Kyung Kwon's work in anti-cancer compositions highlights the potential of combining different compounds to enhance therapeutic effects. His contributions to cancer research are significant and demonstrate the importance of innovation in the medical field.